Best Evidence in Anesthetic Practice Prevention: Recombinant Human Activated Protein C Reduces Mortality in Severe Sepsis

Canadian Journal of Anaesthesia - United States
doi 10.1007/bf03020498
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Activated Protein C in Severe Sepsis

Intensive and Critical Care Nursing
Critical Care Nursing
2001English

Best Evidence in Anesthetic Practice Prevention: Dimenhydrinate Prevents Postoperative Nausea and Vomiting

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2003English

Changes in Protein C Activity in Severe Sepsis.

Nihon Kyukyu Igakukai Zasshi
1998English

A Long-Term Follow-Up Study Investigating Health-Related Quality of Life and Resource Use in Survivors of Severe Sepsis: Comparison of Recombinant Human Activated Protein C With Standard Care

Critical Care
Critical CareIntensive Care Medicine
2008English

Surviving Ratio of Severe Sepsis Treated With Activated Protein C in One University Intensive Care Unit During 2003–2006

Critical Care
Critical CareIntensive Care Medicine
2007English

Activated Protein C Reduces Myocardial Infarct Size and Infarct Expansion in Rats

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2012English

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy

JAMA - Journal of the American Medical Association
Medicine
2019English

Exchange Transfusion in Neonatal Sepsis Dose Not Reduces Overall Mortality

Journal of Evolution of Medical and Dental Sciences
2013English

Introduction: Severe Sepsis and Drotrecogin Alfa (Activated)

Critical Care
Critical CareIntensive Care Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy